APEX1 and acute myeloid leukemia: Therefore, NPM1 mutations in AML result in APEX1 abnormal cytoplasmic accumulation, and impaired base excision repair (BER) activity [29], potentially explaining a chemotherapy improved response in NPM1-mutated AML.